170 related articles for article (PubMed ID: 17492757)
1. Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma.
Parikh RA; White JS; Huang X; Schoppy DW; Baysal BE; Baskaran R; Bakkenist CJ; Saunders WS; Hsu LC; Romkes M; Gollin SM
Genes Chromosomes Cancer; 2007 Aug; 46(8):761-75. PubMed ID: 17492757
[TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.
Sankunny M; Parikh RA; Lewis DW; Gooding WE; Saunders WS; Gollin SM
Genes Chromosomes Cancer; 2014 Feb; 53(2):129-43. PubMed ID: 24327542
[TBL] [Abstract][Full Text] [Related]
3. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q.
Jin Y; Höglund M; Jin C; Martins C; Wennerberg J; Akervall J; Mandahl N; Mitelman F; Mertens F
Genes Chromosomes Cancer; 1998 Aug; 22(4):312-20. PubMed ID: 9669669
[TBL] [Abstract][Full Text] [Related]
4. Relationship between FRA11F and 11q13 gene amplification in oral cancer.
Reshmi SC; Huang X; Schoppy DW; Black RC; Saunders WS; Smith DI; Gollin SM
Genes Chromosomes Cancer; 2007 Feb; 46(2):143-54. PubMed ID: 17099871
[TBL] [Abstract][Full Text] [Related]
5. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.
Takagi M; Yoshida M; Nemoto Y; Tamaichi H; Tsuchida R; Seki M; Uryu K; Nishii R; Miyamoto S; Saito M; Hanada R; Kaneko H; Miyano S; Kataoka K; Yoshida K; Ohira M; Hayashi Y; Nakagawara A; Ogawa S; Mizutani S; Takita J
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059438
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 amplification in chromosomal band 11q13 is associated with overrepresentation of 3q21-q29 in head and neck carcinomas.
Jin Y; Jin C; Wennerberg J; Höglund M; Mertens F
Int J Cancer; 2002 Mar; 98(3):475-9. PubMed ID: 11920603
[TBL] [Abstract][Full Text] [Related]
7. The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma.
González MB; Hernández JM; García JL; Lumbreras E; Castellanos M; Hernández JM; Fernández-Calvo J; Gutiérrez NC; San Miguel JF
Haematologica; 2004 Oct; 89(10):1213-8. PubMed ID: 15477206
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma.
Jin C; Jin Y; Gisselsson D; Wennerberg J; Wah TS; Strömbäck B; Kwong YL; Mertens F
Cytogenet Genome Res; 2006; 115(2):99-106. PubMed ID: 17065789
[TBL] [Abstract][Full Text] [Related]
9. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
[TBL] [Abstract][Full Text] [Related]
10. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer.
Alavi S; Namazie A; Calcaterra TC; Wang MB; Srivatsan ES
Laryngoscope; 1999 Jun; 109(6):874-9. PubMed ID: 10369274
[TBL] [Abstract][Full Text] [Related]
12. Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma.
Mansour WY; Bogdanova NV; Kasten-Pisula U; Rieckmann T; Köcher S; Borgmann K; Baumann M; Krause M; Petersen C; Hu H; Gatti RA; Dikomey E; Dörk T; Dahm-Daphi J
Radiother Oncol; 2013 Jan; 106(1):147-54. PubMed ID: 23199656
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C
J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059
[TBL] [Abstract][Full Text] [Related]
14. Breaks invisible to the DNA damage response machinery accumulate in ATM-deficient cells.
Martín M; Terradas M; Iliakis G; Tusell L; Genescà A
Genes Chromosomes Cancer; 2009 Sep; 48(9):745-59. PubMed ID: 19455703
[TBL] [Abstract][Full Text] [Related]
15. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
[TBL] [Abstract][Full Text] [Related]
16. Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification.
Reshmi SC; Roychoudhury S; Yu Z; Feingold E; Potter D; Saunders WS; Gollin SM
Cytogenet Genome Res; 2007; 116(1-2):46-52. PubMed ID: 17268177
[TBL] [Abstract][Full Text] [Related]
17. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization.
Wang MB; Alavi S; Engstrom M; Lee J; Namazie A; Moatamed F; Srivatsan ES
Anticancer Res; 1999; 19(2A):925-31. PubMed ID: 10368635
[TBL] [Abstract][Full Text] [Related]
18. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.
Austen B; Skowronska A; Baker C; Powell JE; Gardiner A; Oscier D; Majid A; Dyer M; Siebert R; Taylor AM; Moss PA; Stankovic T
J Clin Oncol; 2007 Dec; 25(34):5448-57. PubMed ID: 17968022
[TBL] [Abstract][Full Text] [Related]
19. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
Taylor AM; Groom A; Byrd PJ
DNA Repair (Amst); 2004; 3(8-9):1219-25. PubMed ID: 15279810
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity in squamous cell carcinomas of the head and neck defines a tumor suppressor gene region on 11q13.
Venugopalan M; Wood TF; Wilczynski SP; Sen S; Peters J; Ma GC; Evans GA; Srivatsan ES
Cancer Genet Cytogenet; 1998 Jul; 104(2):124-32. PubMed ID: 9666806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
